In order to probe structure-activity relationships of association with ferriprotoporphyrin IX (log K) and inhibition of -hematin formation, a series of 4-aminoquinolines with varying substituents at the 7-position (X) have been synthesized. These have been further elaborated by introduction of two different R groups on the 4-amino nitrogen atom in the form of methyl (R = Me) and ethylamine (R = EtNH 2 ) side chains. Data for a previously investigated series containing an N,N-diethyl-ethylamine side chain were also compared with the findings of this study. Experimentally, log K values for the simple 4-aminoquinoline series (R = H) were found to correlate with the hydrophobicity constant () of the group X. The log K values for the series with R = Me and EtNH 2 were found to correlate with those of the series with R = H. The log of the 50% -hematin inhibitory activity (log BHIA 50 ) was found to correlate with log K and either meta ( m ) or para ( p ) Hammett constants for the series with R = Me and EtNH 2 , but not the simple series with R = H. To further improve predictability, correlations with ab initio electrostatic parameters, namely Mulliken and CHelpG charges were investigated. The best correlations were found with CHelpG charges which indicated that log K values can be predicted from the charges on atom H-8 and the group X in the quinolinium species computed in vacuum, while log BHIA 50 values can be predicted from the CHelpG charges on C-7, C-8 and N-1 for the neutral species in vacuum. These correlations indicate that association and inhibition of -hematin formation are separately determined. They also suggest that electron withdrawing groups at the 7-position, but not necessarily hydrophobic groups are required for hemozoin inhibition. The upshot is that the correlations imply that considerably more hydrophilic hemozoin inhibitors are feasible.
Introduction
Quinoline antimalarials such as quinine and chloroquine have had a long and successful history. 1 Subsequent emergence of chloroquine resistance has led to the use of other quinoline derivative antimalarials such as mefloquine and amodiaquine. Indeed, the development and clinical deployment of new quinoline antimalarials continues to this day.
For example, piperaquine, a bis-4-aminoquinoline effective against chloroquine-resistant strains that consists of two 4-aminoquinoline moieties attached by a linker has only recently been introduced into clinical use. 2 Ferroquine, a 4-amino-7-chloroquinoline with a ferrocenyl side-chain is currently in phase IIB clinical trials. 3 In addition, research on new quinoline antimalarials retains considerable interest, such as that on so-called "reversed chloroquines"
and related compounds that are both antimalarially active and inhibit the chloroquine resistance mechanism of the parasite.
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The class of 4-aminoquinoline antimalarials are believed to act by inhibiting the incorporation of ferriheme (Fe(III)PPIX), a toxic by-product of hemoglobin digestion, into hemozoin. This is a less toxic insoluble microcrystalline form of Fe(III)PPIX which is produced in the acidic digestive vacuole of the malaria parasite. Indeed, recently chloroquine has been shown to increase free Fe(III)PPIX and decrease hemozoin in the P. falciparum cell in a dose-dependent manner. 11 The detailed mechanism of inhibition has been a matter of debate, with one school of thought proposing that it involves complex formation in solution, [12] [13] [14] while another postulates inhibition of crystal growth via interaction with the crystal surface. 15 It is known that quinolines form complexes with Fe(III)PPIX in solution, 12, 16 while it is also the case that the inhibitory effects of these compounds can be described by a surface interaction model. 15, 17, 18 4
Despite the good efficacy of 4-aminoquinolines in treating malaria, a number of adverse drug effects are known for this class of compound. One of the most important drug liabilities is cardiotoxicity. 19 The human ether-a-go-go related gene (hERG) encodes a K + channel that plays a key role in regulating cardiac action potential. 20 Inhibition of this channel can lead to arrhythmias and in extreme cases heart failure. Cytochrome P450 enzymes (CYPs) are known to be inhibited by many drug candidates and also represent a potential liability for 4-aminoquinolines. 21 Indeed, Gleeson has shown that weak base compounds, of which the 4-aminoquinolines are an example, commonly exhibit adverse properties with respect to hERG toxicity and CYP inhibition. However, the likelihood of such liabilities is reduced in compounds that have decreased lipophilicity (clog P < 4) and relatively low molecular weight (< 400). 22 Thus, suitably modified quinolines may exhibit improved drug toxicity profiles.
In order to design 4-aminoquinolines with improved toxicity profiles, it is a prerequisite to have an understanding of structure-activity relationships at the target level. A large number of 4-aminoquinolines with activity against the parasite are known, but these data are often difficult to interpret because of the complexity of the biological system, which includes factors such as accumulation in the digestive vacuole, access to the parasite and lipophilicity. A number of studies have been undertaken investigating effects of quinoline structure on Fe(III)PPIX association and inhibition of synthetic hemozoin (-hematin)
formation. [23] [24] [25] [26] [27] [28] [29] Some of these have been qualitative, while others have provided some quantitative information. In some cases however, it has been difficult to account for the strong activity of 4-amino-7-chloroquinolines relative to other 4-aminoquinolines. 24, 28 Here we have conducted a structure-activity relationship study to establish the minimum structural criteria for Fe(III)PPIX association and -hematin inhibition in this class 5 of compound. In this endeavor we have started with a series of simple 4-aminoquinolines and built up the lateral side chain to determine the effects on both association constant with Fe(III)PPIX (log K) and 50% -hematin inhibitory activity (BHIA 50 ). This involved preparation of a series of 4-aminoquinolines in which the group at position 7 of the quinoline ring (X) and the lateral side-chain on the 4-amino group (R) were varied (Scheme 1), as well as comparisons with a previous series (R = EtN(Et) 2 in Scheme 1) prepared in our laboratory. 24 The values of log K and log BHIA 50 were then correlated with empirical properties, namely hydrophobicity and Hammett constants and correlations between log BHIA 50 and measured log K values were also explored. Furthermore, correlations with atomic charges, computed using density functional theory (DFT), were also investigated.
Scheme 1

Results
Previous studies on 4-aminoquinolines have shown that association constants with Fe(III)PPIX and ability to inhibit -hematin formation depend on both lipophilic and electronic properties of the group at position 7. [23] [24] [25] For this reason, a series of 4-aminoquinolines with various substituents at position 7 (X) were chosen (Scheme 1). This was done with the aid of a Craig plot of Hammett constant ( p ) versus lipophilicity constant () so as to minimize correlation between these two properties. 30 They were prepared according to well established procedures. Briefly, five 4-chloro-7-X-quinolines were synthesized either by reaction of meta-substituted anilines with diethyl ethoxymethylenemalonate in a five step process with moderate yields or by reaction of the aniline with Meldrum's acid (2,2-dimethyl-1,3-dioxane-4,6-dione) and triethyl orthoformate in a two-step process. Three additional 4-chloro-7-X-quinolines were commercially available (X = Cl, H and CF 3 ). Further modifications to these 7-substituted quinolines were made by varying the lateral side chain at position 4 (Scheme 1). This was accomplished by displacement of the 4-chloro group in an aromatic substitution reaction with either ammonia or two primary amines, namely methylamine or ethanediamine. Finally, compounds with X = NH 2 were prepared from the corresponding 7-nitroquinoline by reduction with SnCl 2 . Full synthetic details for all of the above reactions are supplied as supplementary content.
For each of the compounds synthesized, the log K with Fe(III)PPIX was measured in 40% (v/v) aqueous DMSO. Uv-visible spectroscopic changes were consistent with those reported for compounds which -stack in solution. 31 In addition, all compounds were tested for inhibition of -formation mediated by acetate. The conditions used for measurement of these quantities were chosen to facilitate comparison with previously collected data for a related series of compounds with a N,N-diethylaminoethyl side chain (R = EtN(Et) 2 in Scheme 1). 24 Values of log K and the 50% -hematin inhibitory activity (BHIA 50 ) are presented in Table 1 .
In a previous study of 4-aminoquinolines with R = EtN(Et) 2 , it was found that log K is correlated with the substituent hydrophobicity constant () of the X substituent. 24 A similar correlation is observed for the series prepared here with R = H (Figure 1a ). The same trend is also seen with clog P (not shown). These correlations suggest that the association of the 4-aminoquinoline with Fe(III)PPIX becomes stronger as the substituent X becomes more lipophilic. No correlation between log K and substituent constants was found for the series 7 with R = Me or EtNH 2 . However, a statistically significant correlation (P < 0.05) was found between the log K values for these two series and those for the series with R = H (Figure 1b and c). On the other hand, no correlation of log K for the series with R = EtN(Et) 2 with log K for the series with R = H was found. In the earlier study, using multiple linear correlation analysis (MLCA), a correlation was also found between log BHIA 50 and both log K &  m . 24 In the present work, a similar correlation was found in the series with R = Me (Figure 1d ). In addition, log BHIA 50 also correlated with both log K &  p for both the series with R = Me and EtNH 2 (Figure 1e and f).
A further interesting observation was that there is a simple linear correlation between log BHIA 50 for the series with R = EtNH 2 and the log K values for the corresponding compounds in the R = H series (Figure 1g ). A similar relationship was found between the R = Me and R = H series, but in this case the correlation between log BHIA 50 and log K falls just short of statistical significance at the 95% confidence level. Thus, inhibition of -hematin formation appears to be favored by stronger association with Fe(III)PPIX and by more electron withdrawing X substituents. Somewhat surprisingly, no such correlation between log BHIA 50 and log K was found for the series with R = H itself. However, correlations were found between log BHIA 50 for the series with R = H and those with R = Me and EtNH 2 . As in the case of log K, no such correlation was found for the series with R = EtN(Et) 2 .
Given the role found for electronic properties (Hammett constants) in the inhibition of -hematin formation described above, it was decided to investigate whether there were any correlations between atomic charges on the quinoline moiety calculated using quantum mechanical methods and log K, log BHIA 50 , or both. For this purpose, Mulliken charges were calculated for all atoms in the entire series with R = H as well as three compounds not prepared in this study with R = H and X = F, Br and I. These were calculated for both the neutral and protonated positively charged (quinolinium) forms in both vacuum and aqueous medium using an implicit water model (SMD). 33 In the case of log K, eight statistically significant (P < 0.05) correlations with single atomic charges were found. Using MLCA, two additional correlations were obtained. The best correlation was between log K and the charges on C-6 & C-8a calculated for the neutral form in water (see supplementary content Figure S1 ). Association is predicted to be favored by greater negative charge on C-8a and reduced negative charge on C-6. However, values of log K predicted in this way do not correlate with experimental values for any of the other series.
In the case of log BHIA 50 many correlations with Mulliken atomic charges were found. However, an additional criterion could be used in the selection of more reliable predictors, namely the predicted activity of the compound with X = NH 2 . Although no experimental values could be obtained for derivatives with X = NH 2 because their -hematin inhibitory activities were found to be too weak to measure using the assay, these compounds could be used as test molecules. Only correlations which predicted the corresponding X = NH 2 compound in the series to have a log BHIA 50 higher than the maximum value tested (> A notable observation is that as the lateral side chain becomes more lipophilic, the sensitivity of log BHIA 50 to the identity of the X substituent decreases. This is observed as a decrease in slope in figures 3a -h as log P increases (see supplementary content Figure S3 ). In order to determine whether these observations are likely to be useful in designing new antimalarials, some of the compounds were tested for in vitro antimalarial activity against a chloroquine-sensitive strain of Plasmodium falciparum, NF54. Previous studies on closely related compounds have shown that a weak base N atom is required in the side chain for strong biological activity. 24 This group causes the compound to pH trap in the acidic environment of the digestive vacuole of the parasite. For this reason, only the series with R = EtNH 2 was investigated. The pK a values of the protonated terminal amino group and quinolinium N atom were estimated using the program MarvinSketch. 34 These values, together with calculated log P values are reported in Table 2 . Of particular note is the 7-CN compound. While it was not as active as the 7-Cl and 7-CF 3 compounds, it nonetheless had a low IC 50 of 20 nM. In keeping with previous studies, 8, 24 these compounds showed no direct correlation between IC 50 for inhibition of parasite growth and BHIA 50 (Figure 4a ). However, when the vacuolar accumulation ratio was taken into account, a strong linear correlation was observed (Figure 4b ). Comparison of lipophilicity and biological activity among this entire series of compounds shows that the 7-CN group provides the best combination of strong activity and low lipophilicity (Figure 4c ). 
Discussion
This study was designed to probe relationships between the structures of the simplest Neutral species calculated in vacuum illustrating atoms predictive of -hematin inhibition. Inhibition was found to be favored by decreased positive potential on C-7 (i) and decreased negative potential on both C-8 (ii) and N-1 (iii).
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Similarly atomic charges, particularly CHelpG charges, were good predictors of the trend in log BHIA 50 . Here, the best predictors were the CHelpG charges on N-1 and C-7, with N-1 and C-8 being almost as good. In contrast to the log K prediction, the neutral form (also in vacuum) was found to produce the strongest correlation. Decreased negative potential on N-1 in combination with either a less negative potential on C-8 or a less positive potential on C-7 was found to favor -hematin inhibition (Figure 5b ). The predicted activities for the series with R = H again cross-correlated with the experimental values for the series with R = Me and EtNH 2 and was even found to predict activities in the series reported by Kaschula et al. with R = EtN(Et) 2 . 24 An interesting observation is that the sensitivity of log BHIA 50 to the changes in ESP brought about by altering the X-substituent decreases as the lateral side chain becomes more lipophilic.
Several notable features emerge from this investigation. Atomic charges that predict log K are for the most part not the same as those that predict log BHIA 50 and furthermore the correlations involve different species, namely quinolinium and neutral respectively. Indeed, in the case of the series with R = H there is no experimental correlation between log K and log BHIA 50 , suggesting that inhibition of -hematin formation is not directly related to association between Fe(III)PPIX and the 4-aminoquinoline compound in solution. This appears to support the hypothesis that inhibition of -hematin formation primarily occurs via interaction of the inhibitor with the growing crystal surface, rather than via complex formation in solution. It must be noted however, that there is some correlation between log K and log BHIA 50 as the lateral side chain is lengthened. Thus, a role for solution association cannot necessarily be ruled out for all series of 4-aminoquinoline compounds. Finally, the correlation equations permit the prediction of both log K and log BHIA 50 for these series of [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] aminoquinolines. Interestingly, they do not suggest that the lipophilicity of the group X plays a major role in -hematin inhibition. This is an important finding, since as noted in the introduction there is evidence that less lipophilic and lower molecular weight weak base compounds possess fewer undesirable drug liabilities, such as hERG toxicity. In this regard, it is worth remarking on the observed activity of the analogs with X = CN, which are relatively hydrophilic compared to those with X = Cl, but retain rather strong -hematin inhibitory activity. This indicates that 4-aminoquinolines with improved toxicity properties, but which maintain strong hemozoin-inhibiting characteristics are feasible.
Preliminary investigation of biological activities of compounds in the series with R = EtNH 2 indicate that these findings are indeed likely to be pertinent to the design of new 4-aminoquinoline antimalarials. While there was no direct correlation between activity and strength of inhibition of -hematin formation, the correlation was strong if vacuolar accumulation through pH trapping was taken into account. This is consistent with previous studies on similar families of compounds. 8, 24 However, the strong activity of the 7-CN derivative, a compound with a particularly low lipophilicity is noteworthy. This contrasts with the 7-NO 2 derivative which exhibited poor activity despite being a strong -hematin inhibitor. The weak activity of the latter compound can be ascribed to its particularly strong electron withdrawing effect. This lowers the pK a of the quinolinium NH + group to such an extent that accumulation in the parasite digestive vacuole is too low for it to exert strong biological activity. On the other hand, the 7-CH 3 and -H derivatives appear anomalously active given their weak inhibition of -hematin formation. In this case, the electron releasing characteristics of these groups ensure higher pK a values and hence greater vacuolar accumulation that compensates for weak -hematin inhibition. The 7-CN derivative presents the best compromise of properties if low lipophilicity is desired and is worth pursuing further. 
Conclusion
Compounds with electron withdrawing substituents, namely NO 2 , CN, Cl and CF 3 , were found to be strong inhibitors of β-haematin formation. Additionally, all of the hydrophilic and electron withdrawing compounds with X = CN were found to show strong inhibition of β-haematin formation. Analogs with electron releasing groups at the 7-position were found to be poor inhibitors or non-inhibitors of β-haematin formation.
Derivatives containing electron withdrawing groups at the 7-position were also found to bind strongly to Fe(III)PPIX, while those with electron releasing groups were weaker binders. Lipophilicity was found to be an important factor in Fe(III)PPIX binding. 
Experimental
Synthesis
Chemicals and solvents were purchased from Sigma-Aldrich Chemical Company or Fluka. Column chromatography was carried out using Silica gel 60 from Sigma-Aldrich. Briefly, the compounds investigated were prepared via a series of 4-chloroquinolines with differing substituents at position 7 on the quinoline ring. All of these are known compounds and are available commercially. Full synthetic details of those prepared in this study are provided as Supplementary content. These were prepared in two different ways (see supplementary Schemes S1 and S2). 24, [35] [36] [37] In most cases, the starting materials were 3-X-anilines (X = CH 3 , CN, NO 2 or OCH 3 ) and diethyl ethoxymethylenemalonate which were heated in equimolar ratio at 110 C for 45 -60 min to yield a diethyl 2-((3-Xphenylamino)methylene)malonate. This was then cyclized to a corresponding ethyl-4-hydroxy-7-X-quinoline-3-carboxylate by refluxing in diphenyl ether (265 C) for 30 -60 min. The resulting ester was hydrolyzed by reflux in 2M aqueous NaOH for 30 -60 min yielding the corresponding acid. This was decarboxylated by refluxing in diphenyl ether for 45 -60 min, except for 4-hydroxy-7-nitroquinoline-3-carboxylic acid which was first converted to a silver salt before decarboxylation. 38 The alternative approach involved reacting triethyl orthoformate with a slight excess of 2,2-dimethyl-1,3-dioxane-4,6-dione (Meldrum's acid) to form an intermediate (ethoxymethylene Meldrum's acid) to which 3-X-aniline (X = CONH 2 ) was then added after one hour at 90 C (1 equivalent relative to Meldrum's acid) in 22 situ. The resulting mixture was refluxed for 2 h to yield 3-((2,2-dimethyl-4-6-dioxo-1,3-dioxan-5-ylidene)methylamino)benzamide which was isolated by precipitation from ice cold ethanol. The product was then directly cyclized to 4-hydroxyquinoline-7-carboxamide by refluxing in diphenyl ether for 5 min. 36, 37 This approach was also used as a second method for preparing the derivatives with X = NO 2 or OCH 3 . In a final step, each of the 4-hydroxy-7-Xquinolines was refluxed in excess phosphorus oxychloride (POCl 3 ) for 20 -30 min to yield the corresponding 4-chloro-7-X-quinoline which was then isolated by precipitation after neutralization with ice cold 2 M NaOH. Three additional 4-chloro-7-X-quinolines (X = CF 3 ,
Cl or H) were sourced commercially (Sigma-Aldrich).
The series of 4-amino-7-X-quinolines (X = CH 3 , Cl, CONH 2 , CN, H, NO 2 or OCH 3 )
were prepared by reacting the corresponding 4-chloro-7-X-quinoline with excess aqueous with NH 4 Cl and isolated by evaporation. This product was reduced to the 4-aminoquinoline with a small excess of PPh 3 over 2 h in 1:1 THF/H 2 O at room temperature (supplementary Scheme S4). 39, 40 The product was extracted with aqueous HCl and then into CHCl 3 with 1 M NaOH and isolated by evaporation. Finally, 4,7-diaminoquinoline was prepared from 4-amino-7-nitroquinoline by reduction with excess stannous chloride (SnCl 2 ) over 2 h in HCl and glacial acetic acid at 60 C (supplementary Scheme S5). 41 The product was obtained after base extraction into CHCl 3 with NaOH after stirring, filtering and washing with acetone.
The series of N-methyl-7-X-quinoline-4-amines (X = CH 3 , CF 3 , Cl, CONH 2 , CN, H, NO 2 or OCH 3 ) were prepared by reaction of the corresponding 4-chloro-7-X-quinoline with excess methylamine in a sealed tube at 90 C for 6 h (supplementary Scheme S3). The products were purified by silica gel column chromatography. The compound with X = NH 2 was obtained by reduction of the nitro derivative with SnCl 2 as described for 4,7-diaminoquinoline above (supplementary Scheme S5).
Lastly, the series of N 1 -(7-X-quinolin-4-yl)ethane-1,2-diamines (X = CH 3 , CF 3 , Cl, CN, H, NO 2 or OCH 3 ) was prepared by reaction of the 4-chloro-7-X-quinoline with 5 equivalents of ethylene diamine in a sealed tube at 110 C for 4 -6 h (supplementary Scheme S3). The crude products were obtained after base extraction into CHCl 3 and were purified by preparative HPLC.
Full synthetic details for previously reported compounds are provided as Supplementary content, while details for novel compounds are provided below.
4-Aminoquinolin-7-carboxamide (9d)
7d was heated in a sealed tube with excess aqueous ammonia at 70°C for 4 h. The mixtures were cooled to room temperature and the solid filtered. Solid was then washed with 5% NH 3 (aq.) and dried. Following silica gel chromatography and preparative HPLC where purity was above 98% the product was obtained as a white solid (50 mg, 40%). 
N,7-Dimethylquinolin-4-amine (10a)
7a and excess methylamine (33% in MeOH) were heated in a sealed tube at 90 °C for 6 h.
The mixture was allowed to cool to room temperature and concentrated under reduced pressure. The product was then purified by silica gel chromatography using MeOH: EtOAc: 
N-Methyl-7-(triflouromethyl) quinolin-4-amine (10b)
7b and excess methylamine (33% in MeOH) were heated in a sealed tube at 90 °C for 6 h.
4-(Methylamino)quinolin-7-carboxamide (10d)
7d and excess methylamine (33% in MeOH) were heated in a sealed tube at 90 °C for 6 h.
The mixture was allowed to cool to room temperature and concentrated under reduced 
4-(Methylamino)quinolin-7-carbonitrile (10e)
7e and excess methylamine (33% in MeOH) were heated in a sealed tube at 90 °C for 6 h.
N-Methyl-7-nitroquinolin-4-amine (10h)
7h and excess methylamine (33% in MeOH) were heated in a sealed tube at 90 °C for 6 h.
7-Methoxy-N-methylquinolin-4-amine (10i)
7i and excess methylamine (33% in MeOH) were heated in a sealed tube at 90 °C for 6 h.
N 4 -Methylquinolin-4,7-diamine (10g)
Stannous chloride (SnCl 2 ) (0.87 g, 4.57 mmol) dissolved in concentrated HCl (3 mL) was added slowly to a stirred solution of 10h (0.12 g, 0.57 mmol) in glacial acetic acid (20 mL).
The mixture was stirred at 60 °C for 2 hr. After the mixture was cooled, acetone (50 mL) was added and it was stirred vigorously. Precipitate was collected by filtration, washed with acetone, and suspended in water (250 mL). The suspension was made basic (pH 12) with sodium hydroxide and the product was extracted with chloroform (5 × 50 mL). The crude product was purified by silica gel chromatography with chloroform-methanol (10:1) 
4-(2-Aminoethylamino)quinoline-7-carbonitrile (11e)
7e (1 eq.) and excess (5 eq.) ethylene diamine were heated in a sealed tube at 120 °C for 4-6
h. The reaction mixture was cooled to room temperature and a mixture of 1 M NaOH and 
Biophysical Measurements and in vitro P. falciparum assay
Association constants of the various 4-aminoquinolines with Fe(III)PPIX were determined in 40% aqueous (v/v) DMSO, pH 7.5 by spectrophotometric titration using 29 methods previously described and without modification. 13 The -hematin inhibitory activity was also determined by methods previously reported, again without modification. 42 The assay uses 4.5 M acetate to mediate -hematin formation and 5% aqueous pyridine reacts with unconverted Fe(III)PPIX to form a low-spin bis-pyridyl complex which can be measured colorimetrically.
Compounds 11a -h were tested in vitro against the chloroquine-sensitive NF54 strain of P. falciparum using the [ 3 H]-hypoxanthine incorporation assay, basically as described elsewhere. 43 
Computational methods
DFT calculations on neutral and cationic (quinolinium) structures of 7-substituted 4-aminoquinolines (R = H) were performed using the Gaussian09 software package. 44 Geometry optimizations of all structures were completed in vacuum using the B3LYP functional and 6-31G(d,p) basis set, B3LYP/6-31G(d,p), except in the case of the iodine analog where the iodine atom was described by the 6-311G(d) basis set (retrieved from the EMSL Basis Set Exchange portal) 45 which makes use of a d-type polarization function. 46 Frequencies of final geometry-optimized structures were generated to ensure a stationary point was obtained. In order to test the reliability of the chosen functional and basis set, the structure of CQ was computed and compared to experimental crystal structure data. 47 The average bond length and angle deviations of the quinoline ring were 0.01 Å and 0.5° respectively, indicating this method can produce computed structures in good agreement with experimental data. CHelpG charges were calculated using the B3LYP functional in vacuum or under the implicit water conditions of the SMD solvent model, 33 and were constrained to reproduce the dipole moment. Atoms were described using the larger 6-311+G(2df,p) basis set, B3LYP/6-311+G(2df,p), or in the case of the iodine atom in the X = I molecule, the 6-30 311G(d) basis set (described above for geometry optimization). For bromine and iodine atoms, atomic radii used to determine CHelpG charges were set to the van der Waals radii of 1.85 and 1.98 Ǻ, respectively. 48 CHelpG as well as Mulliken atomic charges (calculated in the same manner as for CHelpG charges) for all 7-substituted 4-aminoquinolines (R = H) in both neutral and quinolinium forms, are listed in supplementary content Tables S2-S5 .
Electrostatic surface potentials were generated using the USCF Chimera software package 49 by mapping the electrostatic potential (obtained using the same functional and basis sets as described for CHelpG atomic charges) onto a density isosurface of 0.002 e.au -3 .
Correlation analyses
Single linear correlation analysis (SLCA) and multiple linear correlation analysis (MLCA) were performed using the computed CHelpG and Mulliken atomic charges for the neutral and quinolinium species in both vacuum and in the implicit SMD water model. In order to facilitate correlations, the atomic charges of any X substituent consisting of two or more atoms were summed to give an overall atomic charge of the X group. For SLCA, a correlation between atomic charge and log K was deemed significant if the P-statistic was less than 0.05. While the same criterion were required for statistical significance between atomic charge and log BHIA 50 , an additional condition was also imposed, namely that the relationship should predict that the log BHIA 50 value for the X = NH 2 molecule be greater than the experimental assay limit (1.30). For MLCA, correlations between atomic charge and log K were deemed significant if they produced a F value greater than F crit at the 95 % confidence level and both correlation coefficients produced a t value greater than t crit at the 95 % confidence level. The same requirements were enforced for correlations between atomic charges and log BHIA 50 , but as in the case of SLCA, the additional criterion of predicting that the log BHIA 50 of the X = NH 2 molecule be greater than 1.30 was also imposed.
